QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the quarterly period ended | ||||||||
OR | ||||||||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the transition period | from ________ to ________ |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
☒ | Accelerated filer | ☐ | |||||||||
Non-accelerated filer | ☐ | Smaller reporting company | |||||||||
Emerging growth company |
Class | Outstanding at July 29, 2024 | ||||||||||
Common Stock, $0.01 par value per share | shares |
Page | ||||||||
Part I. FINANCIAL INFORMATION | ||||||||
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Part II. OTHER INFORMATION | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 5. | ||||||||
Item 6. | ||||||||
June 30, 2024 | December 31, 2023 | ||||||||||
(unaudited) | |||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash and cash equivalents | |||||||||||
Default funds and margin deposits (including restricted cash and cash equivalents of $ | |||||||||||
Financial investments | |||||||||||
Receivables, net | |||||||||||
Other current assets | |||||||||||
Total current assets | |||||||||||
Property and equipment, net | |||||||||||
Goodwill | |||||||||||
Intangible assets, net | |||||||||||
Operating lease assets | |||||||||||
Other non-current assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities | |||||||||||
Current liabilities: | |||||||||||
Accounts payable and accrued expenses | $ | $ | |||||||||
Section 31 fees payable to SEC | |||||||||||
Accrued personnel costs | |||||||||||
Deferred revenue | |||||||||||
Other current liabilities | |||||||||||
Default funds and margin deposits | |||||||||||
Short-term debt | |||||||||||
Total current liabilities | |||||||||||
Long-term debt | |||||||||||
Deferred tax liabilities, net | |||||||||||
Operating lease liabilities | |||||||||||
Other non-current liabilities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies | |||||||||||
Equity | |||||||||||
Nasdaq stockholders’ equity: | |||||||||||
Common stock, $ | |||||||||||
Additional paid-in capital | |||||||||||
Common stock in treasury, at cost: | ( | ( | |||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Retained earnings | |||||||||||
Total Nasdaq stockholders’ equity | |||||||||||
Noncontrolling interests | |||||||||||
Total equity | |||||||||||
Total liabilities and equity | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Capital Access Platforms | $ | $ | $ | $ | |||||||||||||||||||
Financial Technology | |||||||||||||||||||||||
Market Services | |||||||||||||||||||||||
Other revenues | |||||||||||||||||||||||
Total revenues | |||||||||||||||||||||||
Transaction-based expenses: | |||||||||||||||||||||||
Transaction rebates | ( | ( | ( | ( | |||||||||||||||||||
Brokerage, clearance and exchange fees | ( | ( | ( | ( | |||||||||||||||||||
Revenues less transaction-based expenses | |||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Compensation and benefits | |||||||||||||||||||||||
Professional and contract services | |||||||||||||||||||||||
Technology and communication infrastructure | |||||||||||||||||||||||
Occupancy | |||||||||||||||||||||||
General, administrative and other | |||||||||||||||||||||||
Marketing and advertising | |||||||||||||||||||||||
Depreciation and amortization | |||||||||||||||||||||||
Regulatory | |||||||||||||||||||||||
Merger and strategic initiatives | |||||||||||||||||||||||
Restructuring charges | |||||||||||||||||||||||
Total operating expenses | |||||||||||||||||||||||
Operating income | |||||||||||||||||||||||
Interest income | |||||||||||||||||||||||
Interest expense | ( | ( | ( | ( | |||||||||||||||||||
Other income (loss) | ( | ( | |||||||||||||||||||||
Net income (loss) from unconsolidated investees | ( | ||||||||||||||||||||||
Income before income taxes | |||||||||||||||||||||||
Income tax provision | |||||||||||||||||||||||
Net income | |||||||||||||||||||||||
Net loss attributable to noncontrolling interests | |||||||||||||||||||||||
Net income attributable to Nasdaq | $ | $ | $ | $ | |||||||||||||||||||
Per share information: | |||||||||||||||||||||||
Basic earnings per share | $ | $ | $ | $ | |||||||||||||||||||
Diluted earnings per share | $ | $ | $ | $ | |||||||||||||||||||
Cash dividends declared per common share | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
Net income | $ | $ | $ | $ | |||||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Foreign currency translation gains (losses) | ( | ( | ( | ||||||||||||||||||||
Income tax benefit (expense)(1) | ( | ( | |||||||||||||||||||||
Foreign currency translation, net | ( | ( | ( | ||||||||||||||||||||
Employee benefit plan adjustment | |||||||||||||||||||||||
Income tax expense | ( | ||||||||||||||||||||||
Employee benefit plan, net | |||||||||||||||||||||||
Other | ( | ||||||||||||||||||||||
Total other comprehensive income (loss), net of tax | ( | ( | ( | ||||||||||||||||||||
Comprehensive income | |||||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interests | |||||||||||||||||||||||
Comprehensive income attributable to Nasdaq | $ | $ | $ | $ |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||||||||||||||
Shares | $ | Shares | $ | Shares | $ | Shares | $ | ||||||||||||||||||||||||||||||||||||||||
Common stock | |||||||||||||||||||||||||||||||||||||||||||||||
Additional paid-in capital | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Share repurchase program | ( | ( | — | — | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||
Share-based compensation | |||||||||||||||||||||||||||||||||||||||||||||||
Other issuances of common stock, net | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Common stock in treasury, at cost | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Other employee stock activity | — | ( | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||
Ending balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Accumulated other comprehensive loss | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||
Ending balance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Retained earnings | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Net income attributable to Nasdaq | |||||||||||||||||||||||||||||||||||||||||||||||
Cash dividends declared and paid | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Total Nasdaq stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
Noncontrolling interests | |||||||||||||||||||||||||||||||||||||||||||||||
Beginning balance | |||||||||||||||||||||||||||||||||||||||||||||||
Net activity related to noncontrolling interests | — | — | ( | ( | |||||||||||||||||||||||||||||||||||||||||||
Ending balance | |||||||||||||||||||||||||||||||||||||||||||||||
Total Equity | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Depreciation and amortization | |||||||||||
Share-based compensation | |||||||||||
Deferred income taxes | ( | ||||||||||
Extinguishment of debt and bridge fees | |||||||||||
Non-cash restructuring charges | |||||||||||
Net income from unconsolidated investees | ( | ( | |||||||||
Operating lease asset impairments | |||||||||||
Other reconciling items included in net income | |||||||||||
Net change in operating assets and liabilities: | |||||||||||
Receivables, net | ( | ||||||||||
Other assets | |||||||||||
Accounts payable and accrued expenses | ( | ||||||||||
Section 31 fees payable to SEC | ( | ||||||||||
Accrued personnel costs | ( | ( | |||||||||
Deferred revenue | |||||||||||
Other liabilities | ( | ||||||||||
Net cash provided by operating activities | |||||||||||
Cash flows from investing activities: | |||||||||||
Purchases of securities | ( | ( | |||||||||
Proceeds from sales and redemptions of securities | |||||||||||
Purchases of property and equipment | ( | ( | |||||||||
Investments related to default funds and margin deposits, net(1) | ( | ||||||||||
Other investing activities | ( | ||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Repayments of commercial paper, net | ( | ( | |||||||||
Repayments of term loan | ( | ||||||||||
Payment of debt extinguishment cost and bridge fees | ( | ||||||||||
Proceeds from issuances of debt, net of issuance costs | |||||||||||
Repurchases of common stock | ( | ( | |||||||||
Dividends paid | ( | ( | |||||||||
Proceeds received from employee stock activity and other issuances | |||||||||||
Payments related to employee shares withheld for taxes | ( | ( | |||||||||
Default funds and margin deposits | ( | ||||||||||
Net cash provided by (used in) financing activities | ( | ||||||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | ( | ( | |||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents, restricted cash and cash equivalents at beginning of period | |||||||||||
Cash and cash equivalents, restricted cash and cash equivalents at end of period | $ | $ | |||||||||
Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash and cash equivalents | |||||||||||
Restricted cash and cash equivalents (default funds and margin deposits) | |||||||||||
Total | $ | $ | |||||||||
Supplemental Disclosure Cash Flow Information | |||||||||||
Interest paid | $ | $ | |||||||||
Income taxes paid, net of refund | $ | $ |
Three Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
(in millions) | |||||||||||
Capital Access Platforms | |||||||||||
Data & Listing Services | $ | $ | |||||||||
Index | |||||||||||
Workflow & Insights | |||||||||||
Financial Technology | |||||||||||
Financial Crime Management Technology | |||||||||||
Regulatory Technology | |||||||||||
Capital Markets Technology | |||||||||||
Market Services, net | |||||||||||
Other revenues | |||||||||||
Revenues less transaction-based expenses | $ | $ | |||||||||
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
(in millions) | |||||||||||
Capital Access Platforms | |||||||||||
Data & Listing Services | $ | $ | |||||||||
Index | |||||||||||
Workflow & Insights | |||||||||||
Financial Technology | |||||||||||
Financial Crime Management Technology | |||||||||||
Regulatory Technology | |||||||||||
Capital Markets Technology | |||||||||||
Market Services, net | |||||||||||
Other revenues | |||||||||||
Revenues less transaction-based expenses | $ | $ |
Financial Crime Management Technology | Regulatory Technology | Capital Markets Technology | Workflow & Insights | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Remainder of 2024 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
2025 | |||||||||||||||||||||||||||||
2026 | |||||||||||||||||||||||||||||
2027 | |||||||||||||||||||||||||||||
2028 | |||||||||||||||||||||||||||||
2029+ | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
(in millions, except price per share) | |||||
Shares of Nasdaq common stock issued | |||||
Closing price per share of Nasdaq common stock on November 1, 2023 | $ | ||||
Fair value of equity portion of the purchase consideration | $ | ||||
Cash consideration | $ | ||||
Total purchase consideration | $ |
(in millions) | |||||
Goodwill | $ | ||||
Acquired intangible assets | |||||
Receivables, net | |||||
Other net assets acquired | |||||
Cash and cash equivalents | |||||
Accrued personnel costs | ( | ||||
Deferred revenue | ( | ||||
Deferred tax liability on acquired intangible assets | ( | ||||
Total purchase consideration | $ |
Customer Relationships | Technology | Trade Names | Total Acquired Intangible Assets | |||||||||||
Intangible asset value (in millions) | $ | $ | $ | $ | ||||||||||
Discount rate used | % | % | % | |||||||||||
Estimated average useful life |
(in millions) | |||||
Capital Access Platforms | |||||
Balance at December 31, 2023 | $ | ||||
Foreign currency translation adjustments | ( | ||||
Balance at June 30, 2024 | $ | ||||
Financial Technology | |||||
Balance at December 31, 2023 | $ | ||||
Foreign currency translation adjustments | ( | ||||
Balance at June 30, 2024 | $ | ||||
Market Services | |||||
Balance at December 31, 2023 | $ | ||||
Foreign currency translation adjustments | ( | ||||
Balance at June 30, 2024 | $ | ||||
Total | |||||
Balance at December 31, 2023 | $ | ||||
Foreign currency translation adjustments | ( | ||||
Balance at June 30, 2024 | $ |
June 30, 2024 | December 31, 2023 | ||||||||||
Finite-Lived Intangible Assets | (in millions) | ||||||||||
Gross Amount | |||||||||||
Technology | $ | $ | |||||||||
Customer relationships | |||||||||||
Trade names and other | |||||||||||
Foreign currency translation adjustment | ( | ( | |||||||||
Total gross amount | $ | $ | |||||||||
Accumulated Amortization | |||||||||||
Technology | $ | ( | $ | ( | |||||||
Customer relationships | ( | ( | |||||||||
Trade names and other | ( | ( | |||||||||
Foreign currency translation adjustment | |||||||||||
Total accumulated amortization | $ | ( | $ | ( | |||||||
Net Amount | |||||||||||
Technology | $ | $ | |||||||||
Customer relationships | |||||||||||
Trade names and other | |||||||||||
Foreign currency translation adjustment | ( | ( | |||||||||
Total finite-lived intangible assets | $ | $ | |||||||||
Indefinite-Lived Intangible Assets | |||||||||||
Exchange and clearing registrations | $ | $ | |||||||||
Trade names | |||||||||||
Licenses | |||||||||||
Foreign currency translation adjustment | ( | ( | |||||||||
Total indefinite-lived intangible assets | $ | $ | |||||||||
Total intangible assets, net | $ | $ | |||||||||
Three Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
(in millions) | |||||||||||
Amortization expense | $ | $ | |||||||||
Six Months Ended June 30, | |||||||||||
2024 | 2023 | ||||||||||
(in millions) | |||||||||||
Amortization expense | $ | $ |
(in millions) | |||||
Remainder of 2024 | $ | ||||
2025 | |||||
2026 | |||||
2027 | |||||
2028 | |||||
2029+ | |||||
Total | $ |
June 30, 2024 | December 31, 2023 | ||||||||||
(in millions) | |||||||||||
Financial investments | $ | $ | |||||||||
Equity method investments | |||||||||||
Equity securities |
Balance at December 31, 2023 | Additions | Revenue Recognized | Foreign Currency Translation Adjustments | Balance at June 30, 2024 | |||||||||||||
(in millions) | |||||||||||||||||
Capital Access Platforms: | |||||||||||||||||
Initial Listings | $ | $ | $ | ( | $ | ( | $ | ||||||||||
Annual Listings | ( | ( | |||||||||||||||
Workflow & Insights | ( | ||||||||||||||||
Financial Technology: | |||||||||||||||||
Financial Crime Management Technology | ( | ( | |||||||||||||||
Regulatory Technology | ( | ( | |||||||||||||||
Capital Markets Technology | ( | ( | |||||||||||||||
Other | ( | ( | |||||||||||||||
Total | $ | $ | $ | ( | $ | ( | $ | ||||||||||
Fiscal year ended: | 2024 | 2025 | 2026 | 2027 | 2028 | 2029+ | Total | ||||||||||||||||
(in millions) | |||||||||||||||||||||||
Capital Access Platforms: | |||||||||||||||||||||||
Initial Listings | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||
Annual Listings | |||||||||||||||||||||||
Workflow & Insights | |||||||||||||||||||||||
Financial Technology: | |||||||||||||||||||||||
Financial Crime Management Technology | |||||||||||||||||||||||
Regulatory Technology | |||||||||||||||||||||||
Capital Markets Technology | |||||||||||||||||||||||
Other |